Treatment of High-risk Myelodysplastic Syndrome
In: Zhongliu Fangzhi Yanjiu, Jg. 47 (2020), Heft 12, S. 996-1002
Online
academicJournal
Zugriff:
Myelodysplastic syndrome (MDS) is a kind of hematological malignancies, characterized by malignant clones in hematopoietic stem cells. The treatment mainly focused on epigenetic treatment, chemotherapy, stem cell transplantation and new drugs. This article summarized all these kinds of treatments.
Titel: |
Treatment of High-risk Myelodysplastic Syndrome
|
---|---|
Autor/in / Beteiligte Person: | Shijun, LI ; Junyuan, QI |
Link: | |
Zeitschrift: | Zhongliu Fangzhi Yanjiu, Jg. 47 (2020), Heft 12, S. 996-1002 |
Veröffentlichung: | Magazine House of Cancer Research on Prevention and Treatment, 2020 |
Medientyp: | academicJournal |
ISSN: | 1000-8578 (print) |
DOI: | 10.3971/j.issn.1000-8578.2020.20.0412 |
Schlagwort: |
|
Sonstiges: |
|